Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Public Health ; 234: 98-104, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-38972230

RESUMEN

OBJECTIVES: To estimate the size of COVID-19 waves using four indicators across three pandemic periods and assess potential surveillance bias. STUDY DESIGN: Case study using data from one region of Switzerland. METHODS: We compared cases, hospitalizations, deaths, and seroprevalence during three periods including the first three pandemic waves (period 1: Feb-Oct 2020; period 2: Oct 2020-Feb 2021; period 3: Feb-Aug 2021). Data were retrieved from the Federal Office of Public Health or estimated from population-based studies. To assess potential surveillance bias, indicators were compared to a reference indicator, i.e. seroprevalence during periods 1 and 2 and hospitalizations during the period 3. Timeliness of indicators (the duration from data generation to the availability of the information to decision-makers) was also evaluated. RESULTS: Using seroprevalence (our reference indicator for period 1 and 2), the 2nd wave size was slightly larger (by a ratio of 1.4) than the 1st wave. Compared to seroprevalence, cases largely overestimated the 2nd wave size (2nd vs 1st wave ratio: 6.5), while hospitalizations (ratio: 2.2) and deaths (ratio: 2.9) were more suitable to compare the size of these waves. Using hospitalizations as a reference, the 3rd wave size was slightly smaller (by a ratio of 0.7) than the 2nd wave. Cases or deaths slightly underestimated the 3rd wave size (3rd vs 2nd wave ratio for cases: 0.5; for deaths: 0.4). The seroprevalence was not useful to compare the size of these waves due to high vaccination rates. Across all waves, timeliness for cases and hospitalizations was better than for deaths or seroprevalence. CONCLUSIONS: The usefulness of indicators for assessing the size of pandemic waves depends on the type of indicator and the period of the pandemic.


Asunto(s)
Sesgo , COVID-19 , Hospitalización , SARS-CoV-2 , Humanos , COVID-19/epidemiología , Estudios Seroepidemiológicos , Hospitalización/estadística & datos numéricos , Suiza/epidemiología , Pandemias , Vigilancia de la Población/métodos
2.
Compr Psychiatry ; 130: 152457, 2024 04.
Artículo en Inglés | MEDLINE | ID: mdl-38325041

RESUMEN

Previous mental health trajectory studies were mostly limited to the months before access to vaccination. They are not informing on whether public mental health has adapted to the pandemic. The aim of this analysis was to 1) investigate trajectories of monthly reported depressive symptoms from July 2020 to December 2021 in Switzerland, 2) compare average growth trajectories across regions with different stringency phases, and 3) explore the relative impact of self-reported worries related to health, economic and social domains as well as socio-economic indicators on growth trajectories. As part of the population-based Corona Immunitas program of regional, but harmonized, adult cohorts studying the pandemic course and impact, participants repeatedly reported online to the DASS-21 instrument on depressive symptomatology. Trajectories of depressive symptoms were estimated using a latent growth model, specified as a generalised linear mixed model. The time effect was modelled parametrically through a polynomial allowing to estimate trajectories for participants' missing time points. In all regions level and shape of the trajectories mirrored those of the KOF Stringency-Plus Index, which quantifies regional Covid-19 policy stringency. The higher level of average depression in trajectories of those expressing specific worries was most noticeable for the social domain. Younger age, female gender, and low household income went along with higher mean depression score trajectories throughout follow-up. Interventions to promote long-term resilience are an important part of pandemic preparedness, given the observed lack of an adaptation in mental health response to the pandemic even after the availability of vaccines in this high-income context.


Asunto(s)
COVID-19 , Depresión , Adulto , Humanos , Femenino , Depresión/diagnóstico , Depresión/epidemiología , Depresión/psicología , COVID-19/epidemiología , Pandemias , Suiza/epidemiología , Ansiedad
3.
Paediatr Anaesth ; 14(9): 774-7, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15330961

RESUMEN

Tracheal agenesis is a potentially lethal congenital anomaly, appearing only at birth. We describe a newborn preterm infant who presented with immediate respiratory distress and no audible cry. There was almost complete tracheal agenesis with a very short segment of distal trachea (only two tracheal rings) arising from the anterior wall of the esophagus, before dividing into the mainstem bronchi. The anomaly was unsuspected prenatally, as the scan showed pyloric atresia and complex congenital cardiac disease. Despite the patient's difficult course, with correction of the rare-associated malformations (cardiac and gastrointestinal tract anomalies), the fact that the child is lively and neurologically normal for her age, requires that we now consider the patency of the airway and the possibility of surgical correction, in accordance with a good quality of life.


Asunto(s)
Anomalías Múltiples , Procedimientos Quirúrgicos del Sistema Digestivo/métodos , Anomalías del Sistema Respiratorio/diagnóstico , Tráquea/anomalías , Fístula Traqueoesofágica/diagnóstico , Traqueostomía/métodos , Cateterismo Cardíaco , Procedimientos Quirúrgicos Cardíacos , Cateterismo , Anomalías del Sistema Digestivo/diagnóstico , Anomalías del Sistema Digestivo/cirugía , Esófago/anomalías , Esófago/cirugía , Femenino , Estudios de Seguimiento , Cardiopatías Congénitas/diagnóstico por imagen , Cardiopatías Congénitas/cirugía , Humanos , Imagenología Tridimensional , Lactante , Laringe/diagnóstico por imagen , Enfermedades Raras , Anomalías del Sistema Respiratorio/cirugía , Stents , Tomografía Computarizada por Rayos X , Fístula Traqueoesofágica/cirugía , Ultrasonografía
4.
J Chem Inf Comput Sci ; 16(3): 128-30, 1976 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-1010857

RESUMEN

This paper describes collaborative efforts between the National Cancer Institute (NCI) and the National Library of Medicine) (NLM) for the development of a new data base called CANCERLINE. The scope content, and future enhancements of this on-line file are discussed, as well as the plans for its use to disseminate cancer-related information via NLM's biomedical communications network.


Asunto(s)
Sistemas de Información , Neoplasias , Sistemas en Línea , National Institutes of Health (U.S.) , National Library of Medicine (U.S.) , Estados Unidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA